Taken together, our findings on the differential roles of butyrate in cell proliferation and the activation of ERK1/2, histone hyperacetylation, and c-Myc, p21 protein abundance and intracellular location in cancerous HCT116 and noncancerous NCM460 colon cells may, at least in part, account for the selective potential of butyrate’s anticancer colon cancer action. This evidence concerns the gene MYC and colonic neoplasm.